Today we dive into two rare but life-disrupting sleep disorders: narcolepsy and idiopathic hypersomnia. People with these conditions don’t just feel tired — they can fall asleep suddenly while driving, talking, or working, or sleep 11+ hours and still feel completely unrefreshed with intense brain fog and sleep drunkenness. Our guest is world-renowned sleep expert Dr. Logan Schneider, board-certified neurologist and sleep medicine specialist, Adjunct Clinical Associate Professor at Stanford University, and Clinical Lead for Sleep Health at Google. We cover causes (including the loss of the brain chemical orexin/hypocretin), symptoms like cataplexy, diagnosis, the only FDA-approved medication for idiopathic hypersomnia (Xywav), made by Jazz Pharmaceuticals @JazzPharma, lifestyle strategies, common myths, and how to find the right specialist. Timestamps: 0:00 – Introduction & episode overview 1:07 – Meet Dr. Logan Schneider 2:06 – What are sleep disorders and why they matter 3:12 – How common is excessive daytime sleepiness? 5:28 – What is narcolepsy and its main symptoms 6:55 – Sleep attacks and the danger of falling asleep while driving 8:04 – Type 1 narcolepsy: the orexin/hypocretin deficiency 10:25 – Is it autoimmune? What triggers it? 10:29 – How is narcolepsy diagnosed? 12:10 – Narcolepsy Type 2 explained 13:42 – What is cataplexy and REM sleep? 15:07 – Who gets narcolepsy (age & gender) 16:55 – Idiopathic hypersomnia: how it differs from narcolepsy 18:24 – Sleeping 9–11 hours and still exhausted 19:24 – Brain fog and “sleep drunkenness” 21:06 – Does coffee help these disorders? 22:39 – Xywav (low-sodium oxybate): how it works for both conditions 26:32 – Why the low-sodium version matters for heart health 28:56 – REMS program and why it’s a controlled substance 31:45 – Who is a candidate for Xywav? 35:33 – Lifestyle tips and support strategies 37:02 – Common misconceptions about these disorders 40:08 – Do you need a sleep study before treatment? 42:10 – Who can prescribe Xywav? 44:14 – How to find a sleep specialist near you 45:50 – Final message: “Sleepiness is red alert” Subscribe for more expert medical interviews! #Narcolepsy #IdiopathicHypersomnia #SleepDisorders #ExcessiveDaytimeSleepiness #Cataplexy #Xywav #SleepMedicine #BrainFog #Hypersomnia #NarcolepsyAwareness #SleepHealth #DoctorPodcasts #Cykiert #sleep

CRISPR gene editing is no longer science fiction — it’s an FDA-approved treatment transforming lives with sickle cell disease and beta-thalassemia. In this episode of the DoctorPodcasts, host Dr. Robert Cykiert sits down with Dr. Akshay Sharma, Associate Member at St. Jude Children’s Research Hospital and a leading expert in gene therapy and bone marrow transplantation. Dr. Sharma was involved in the clinical trials that led to the approval of Casgevy. Discover how a single DNA edit can raise fetal hemoglobin, stop painful crises, and potentially free patients from lifelong transfusions and organ damage. Learn the real differences between gene therapy and traditional bone marrow transplant, the full treatment timeline, risks (including busulfan chemotherapy), expansion to younger patients, and how AI could accelerate the next generation of cures. This is one of the most important medical breakthroughs of our time. Timeline / Chapters: 0:00 – Introduction & Guest Welcome 2:16 – What is Sickle Cell Disease? The Genetic Defect Explained 5:37 – Inheritance Pattern & How Many People Are Affected 7:04 – Sickle Cell Trait vs. Disease 7:50 – Historical Treatments: Supportive Care, Hydroxyurea & More 12:23 – Bone Marrow Transplant History (First Success at St. Jude in 1983) 13:27 – What is Beta-Thalassemia? 15:40 – How Casgevy Differs from Transfusions & Transplants 20:25 – How CRISPR Gene Editing Works (The Molecular Scissors) 25:48 – Clinical Trials, FDA Approval (Dec 2023) & Age Expansion 30:36 – Treating Young Children: Long-Term Outlook 34:54 – Full Treatment Timeline (9–12 Months) 37:12 – Role of AI in Future Gene Therapies 39:35 – Closing Thoughts #Casgevy, #CRISPR, #sickle #thalassemia, #gene #hemoglobin, #bonemarrowtransplant, , , , #Vertex #CRISPR #DNA #Doctorpodcasts #Cykiert Subscribe for more expert interviews on breakthrough medical treatments. Like, share, and comment with your questions!

🎬Welcome to Episode 157 of the DoctorPodcasts Show! In this episode, host Dr. Robert Cykiert interviews board-certified ophthalmologist and oculoplastic surgeon Dr. Amy Patel Jain, M.D. to discuss a condition affecting thousands of people every day: Thyroid Eye Disease (TED). As a co-investigator in pivotal clinical trials, Dr. Patel Jain shares her deep expertise on how TED impacts patients' eyes and quality of life. We dive into traditional surgical treatments like orbital decompression, the paradigm shift brought on by #Tepezza, and breaking news regarding the June 2026 FDA approval of a brand-new five-infusion targeted biologic treatment: #Lumvoa.If you or a loved one are navigating the challenges of this autoimmune condition, this deep-dive interview offers the clinical insights and treatment options you need to know.

Don't forget to SUBSCRIBE, FOLLOW, LIKE, and REPOST to help us spread awareness!⏳ Video Timeline (Chapters)

0:00 — Introduction to Episode 157 & Guest Dr. Amy Patel Jain

2:02 — What is Thyroid Eye Disease (TED) and How Does it Affect the Eyes?

3:26 — TED vs. Graves' Disease: Can You Have TED Without an Active Thyroid Problem?

4:21 — What Causes TED? The Role of TSH and IGF-1R Receptors5:08 — Who is at Risk? Demographics, Genetics, and the Impact of Smoking

7:10 — How Many People in the USA Are Affected by TED?

7:24 — Types of TED: Acute vs. Chronic and Active vs. Inactive Inflammation

10:05 — How TED Affects Patient Quality of Life, Mental Health, and Daily Functioning

11:19 — Traditional TED Treatments: Steroids, Radiation, and Multi-Stage Surgery

13:25 — How Orbital Decompression Surgery Works (The "Ice Cream Cone" Analogy)

15:25 — The Impact of Tepezza: A Paradigm Shift in Medical Treatment

16:24 — Breaking News: How the New Drug Lumvoa Works (Mechanism of Action)

17:33 — Lumvoa vs. Tepezza: Comparing Infusion Times, Frequency, and Treatment Burden

18:35 — Clinical Results: How Quickly Do Patients See Results with Lumvoa?

19:13 — Why TED Causes Diplopia (Double Vision) & Asymmetric Muscle Expansion

20:39 — Main Side Effects and Clinical Considerations (Hypoglycemia, Hearing Changes, IBD)

22:19 — Who is the Ideal Candidate for Lumvoa & Navigating the Viridian Cares Program

24:18 — Will Biologics Reduce the Need for Severe Orbital Decompression Surgeries?

25:42 — Outro & Closing Remarks

🏷️ #ThyroidEyeDisease #TED #Lumvoa #Tepezza #GravesDisease #BulgingEyes #Ophthalmology #AutoimmuneDisease #DoubleVision #ThyroidAwareness #DoctorPodcastsShow #proptosis #exophthalmos Medical Disclaimer: This video is for informational and educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.